Enliven Therapeutics, Inc. — SC 13D/A Filings
13 SC 13D/A filings on record
This page lists all SC 13D/A filings submitted to the SEC by Enliven Therapeutics, Inc. (ELVN), sorted by most recent first. Each row links to the full filing on EdgarLookup. Enliven Therapeutics, Inc. has filed 13 SC 13D/A documents with the SEC since 2016. To view all SEC filings by Enliven Therapeutics, Inc., see the full filings list.
All
10-K
10-Q
144
144/A
3
4
4/A
424B3
424B4
424B5
425
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DEFM14A
DRS
DRS/A
DRSLTR
EFFECT
PRE 14A
PREM14A
S-1
S-1/A
S-3
S-3ASR
S-3MEF
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13D/A | SC 13D/A | 0001104659-24-083627 | Jul 29, 2024 | — |
| SC 13D/A | AMENDMENT NO. 2 | 0000947871-24-000499 | May 20, 2024 | — |
| SC 13D/A | SC 13D/A | 0001104659-24-047395 | Apr 15, 2024 | — |
| SC 13D/A | AMENDMENT NO. 1 | 0000947871-24-000350 | Apr 4, 2024 | — |
| SC 13D/A | SC 13D/A | 0001104659-24-024915 | Feb 16, 2024 | — |
| SC 13D/A | SC 13D/A | 0001104659-24-010043 | Feb 2, 2024 | — |
| SC 13D/A | SC 13D/A | 0001104659-23-095997 | Aug 28, 2023 | — |
| SC 13D/A | NEW ENTERPRISE ASSOCIATES 14, L.P. -- IMARA INC. 13DA3E | 0001072613-22-000435 | May 24, 2022 | — |
| SC 13D/A | NEW ENTERPRISE ASSOCIATES 14, L.P. -- IMARA INC. 13DA2 | 0001072613-22-000392 | Apr 25, 2022 | — |
| SC 13D/A | NEW ENTERPRISE ASSOCIATES 14, L.P. -- IMARA INC. 13DA1 | 0001072613-22-000025 | Jan 10, 2022 | — |
| SC 13D/A | SC 13D/A | 0001193125-21-219665 | Jul 20, 2021 | — |
| SC 13D/A | SC 13D/A | 0001193125-21-005217 | Jan 8, 2021 | — |
| SC 13D/A | SC 13D/A | 0001193125-20-310790 | Dec 4, 2020 | — |